Which has stronger earnings and valuation, XOMAP or ALVOW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio XOMA $7.65M N/A N/A N/A N/A Alvotech $559.42M N/A N/A N/A N/A

Is XOMAP or ALVOW more profitable?

Company Net Margins Return on Equity Return on Assets XOMA N/A N/A N/A Alvotech N/A N/A N/A

Which has higher earnings & valuation, XOMAP or APLMW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio XOMA $7.65M N/A N/A N/A N/A Apollomics $8.50M N/A N/A N/A N/A

Is XOMAP or APLMW more profitable?

Company Net Margins Return on Equity Return on Assets XOMA N/A N/A N/A Apollomics N/A N/A N/A

Which has preferable valuation and earnings, XOMAP or ARAV?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio XOMA $7.65M N/A N/A N/A N/A Aravive N/A N/A N/A -$0.90 N/A

Is XOMAP or ARAV more profitable?

Company Net Margins Return on Equity Return on Assets XOMA N/A N/A N/A Aravive N/A N/A N/A

Which has stronger valuation and earnings, XOMAP or BIAFW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio XOMA $7.65M N/A N/A N/A N/A bioAffinity Technologies $5.85M N/A N/A N/A N/A

Is XOMAP or BIAFW more profitable?

Company Net Margins Return on Equity Return on Assets XOMA N/A N/A N/A bioAffinity Technologies N/A N/A N/A

Which has higher valuation & earnings, XOMAP or BIVIW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio XOMA $7.65M N/A N/A N/A N/A BioVie N/A N/A N/A N/A N/A

Is XOMAP or BIVIW more profitable?

Company Net Margins Return on Equity Return on Assets XOMA N/A N/A N/A BioVie N/A N/A N/A

XOMA (XOMAP) Competitors

$24.98 0.00 (0.00%)

As of 08/13/2026

Compare

XOMAP vs. ALVOW, APLMW, ARAV, BIAFW, and BIVIW

Should you buy XOMA stock or one of its competitors? XOMA's main competitors and comparable companies include Alvotech (ALVOW), Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), and BioVie (BIVIW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does XOMA compare to Alvotech?

XOMA (NASDAQ:XOMAP) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends, institutional ownership and media sentiment.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
XOMA	$7.65M	N/A	N/A	N/A	N/A
Alvotech	$559.42M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
XOMA	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

In the previous week, Alvotech had 2 more articles in the media than XOMA. MarketBeat recorded 2 mentions for Alvotech and 0 mentions for XOMA. Alvotech's average media sentiment score of 0.93 beat XOMA's score of 0.00 indicating that Alvotech is being referred to more favorably in the news media.

Company	Overall Sentiment
XOMA	Neutral
Alvotech	Positive

Summary

Alvotech beats XOMA on 3 of the 3 factors compared between the two stocks.

How does XOMA compare to Apollomics?

XOMA (NASDAQ:XOMAP) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, risk, earnings, analyst recommendations and profitability.

Company	Net Margins	Return on Equity	Return on Assets
XOMA	N/A	N/A	N/A
Apollomics	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
XOMA	$7.65M	N/A	N/A	N/A	N/A
Apollomics	$8.50M	N/A	N/A	N/A	N/A

In the previous week, Apollomics had 3 more articles in the media than XOMA. MarketBeat recorded 3 mentions for Apollomics and 0 mentions for XOMA. Apollomics' average media sentiment score of 0.29 beat XOMA's score of 0.00 indicating that Apollomics is being referred to more favorably in the news media.

Company	Overall Sentiment
XOMA	Neutral
Apollomics	Neutral

Summary

Apollomics beats XOMA on 3 of the 3 factors compared between the two stocks.

How does XOMA compare to Aravive?

XOMA (NASDAQ:XOMAP) and Aravive (NASDAQ:ARAV) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Company	Net Margins	Return on Equity	Return on Assets
XOMA	N/A	N/A	N/A
Aravive	N/A	N/A	N/A

In the previous week, XOMA's average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company	Overall Sentiment
XOMA	Neutral
Aravive	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
XOMA	$7.65M	N/A	N/A	N/A	N/A
Aravive	N/A	N/A	N/A	-$0.90	N/A

Summary

Aravive beats XOMA on 2 of the 3 factors compared between the two stocks.

How does XOMA compare to bioAffinity Technologies?

XOMA (NASDAQ:XOMAP) and bioAffinity Technologies (NASDAQ:BIAFW) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

Company	Net Margins	Return on Equity	Return on Assets
XOMA	N/A	N/A	N/A
bioAffinity Technologies	N/A	N/A	N/A

In the previous week, bioAffinity Technologies had 3 more articles in the media than XOMA. MarketBeat recorded 3 mentions for bioAffinity Technologies and 0 mentions for XOMA. bioAffinity Technologies' average media sentiment score of 0.73 beat XOMA's score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
XOMA	Neutral
bioAffinity Technologies	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
XOMA	$7.65M	N/A	N/A	N/A	N/A
bioAffinity Technologies	$5.85M	N/A	N/A	N/A	N/A

Summary

bioAffinity Technologies beats XOMA on 2 of the 3 factors compared between the two stocks.

How does XOMA compare to BioVie?

XOMA (NASDAQ:XOMAP) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings and profitability.

Company	Net Margins	Return on Equity	Return on Assets
XOMA	N/A	N/A	N/A
BioVie	N/A	N/A	N/A

In the previous week, BioVie had 2 more articles in the media than XOMA. MarketBeat recorded 2 mentions for BioVie and 0 mentions for XOMA. BioVie's average media sentiment score of 1.23 beat XOMA's score of 0.00 indicating that BioVie is being referred to more favorably in the news media.

Company	Overall Sentiment
XOMA	Neutral
BioVie	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
XOMA	$7.65M	N/A	N/A	N/A	N/A
BioVie	N/A	N/A	N/A	N/A	N/A

Summary

BioVie beats XOMA on 2 of the 3 factors compared between the two stocks.

Get XOMA News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XOMAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XOMAP vs. The Competition

Export

Metric	XOMA	Biotechnology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$3.71B	$6.98B	$13.04B
Dividend Yield	9.29%	3.76%	2.58%	10.72%
P/E Ratio	N/A	10.68	269.86	25.30
Price / Sales	N/A	1,308.25	601.81	101.06
Price / Cash	N/A	103.01	70.53	50.75
Price / Book	N/A	17.49	13.08	6.33
Net Income	N/A	-$13.32M	$3.45B	$347.70M
7 Day Performance	N/A	1.74%	1.12%	1.07%
1 Month Performance	-0.04%	1.60%	1.79%	1.03%
1 Year Performance	-3.01%	56.43%	67.69%	20.77%

XOMA Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XOMAP XOMA	N/A	$24.98 flat	N/A	N/A	$0.00	$7.65M	N/A	10
ALVOW Alvotech	N/A	$0.15 flat	N/A	-87.2%	$0.00	$559.42M	N/A	4	Upcoming Earnings
APLMW Apollomics	N/A	$0.02 -1.6%	N/A	-30.7%	$0.00	$8.50M	N/A	59	Short Interest Increase Gap Down
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
BIAFW bioAffinity Technologies	N/A	$0.08 +9.1%	N/A	-26.6%	$0.00	$5.61M	N/A	10	News Coverage Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XOMAP) was last updated on 8/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

XOMA (XOMAP) Competitors